Marker Therapeutics, Inc. (MRKR) income statement
MRKRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.09−0.23 (-17.42%)
Close on Nov 20, 2026Market cap $18.17MP/E –Yield –
Marker Therapeutics, Inc. financial ratios
See a number that looks wrong?